QGEN: Qiagen Company Aggregate Debts

Symbol and logo of brand qiagen.com (QGEN)

Is it worth investing in a business with a powerful patent shield and customer lock-in via consumables? The overall debt position provides the answer, where the 1.64 indicator expresses the state of the metric. Global instability hindering system exports creates risks. Meanwhile, Thierry Bernard ensures management stability by focusing on test automation and leadership in molecular diagnostics for Qiagen N.V. (QGEN).

Qiagen N.V. (QGEN) Company Aggregate Debts: for the period 07/04/2022 - 10/30/2026
Signature product of Qiagen

When screening business quality, an investor assesses financial stability through the level of debt load. This indicator captures the ratio of total borrowings to the company's equity. For Qiagen N.V. (QGEN), such funds are invested in protecting the patent portfolio and creating an ecosystem of consumables. High laboratory dependency on equipment minimizes loan service risks. The dynamics of total liabilities allow for the determination of the balance between expansion and solvency.

Competitors of Qiagen N.V.

Tempus AI, Inc. - Company Aggregate Debt|Company Aggregate Debts IONS (Ionis Pharmaceuticals)|Company Aggregate Debts repligen.com RGEN|RNA - Company Debts|Company Total Indebtedness CRISPR Therapeutics Inc (CRSP)|WGS: Company Aggregate Debts|RARE - Company Total Debt Obligations|BEAM (Beam Therapeutics Inc.) - Company Aggregate Debts|Company Aggregate Debts sarepta.com|Company Aggregate Debts TWST|10x Genomics Inc (TXG) - Company Total Indebtedness|Company Aggregate Debts NTLA (Intellia)|Stoke Corp (STOK) - Company Cumulative Debt|BLFS - Company Debts|WVE (wavelifesciences.com) - Company Aggregate Debt|MAZE (Maze Therapeutics) - Company Total Debt|Sionna Therapeutics, Inc. - Aggregate Debt Obligations|Company Debts Prime Medicine Corp|Company Aggregate Debt TSHA (Taysha Corp)|Company Total Debt QURE (uniQure N.V.)|Company Total Debt Obligations meiragtx.com|REGENXBIO - Company Total Debt|Solid Biosciences Inc - Company Debts|OCGN: Company Total Debt|Company Total Debt Obligations PacBio Corp PACB|Benitec Biopharma Inc. (BNTC) - Company Debts|Company Total Indebtedness designtx.com DSGN|RCKT (Rocket Pharmaceuticals, Inc.) - Company Aggregate Debts|FDMT - Company Total Indebtedness|Company Aggregate Debts LXEO|KRRO - Company Cumulative Debt|Company Debts Editas Medicine, Inc. EDIT|SLN: Company Aggregate Debt|ProQR Therapeutics NV - Company Aggregate Debts|CDXS (Codexis, Inc.) - Company Aggregate Debt|Sangamo (SGMO) - Company Debts|Company Aggregate Debt NAUT|MGX (Metagenomi, Inc.) - Company Aggregate Debts|Company Aggregate Debts precisionbiosciences.com|Company Debts Generation Bio Co. (GBIO)|Boundless Bio Inc. (BOLD) - Company Total Indebtedness|Company Aggregate Debts XCUR (Exicure)|Company Total Debt Obligations Imunon Inc (IMNN)|RXi Pharmaceuticals - Company Aggregate Debts|MBIO - Company Aggregate Debts|RNAZ: Company Aggregate Debts|Company Total Indebtedness Bionano Genomics BNGO|APDN (Applied DNA) - Company Aggregate Debts|Company Cumulative Debt bluebird bio, Inc BLUE|Company Debts ImmunoPrecise Antibodies (IPA)|omegatherapeutics.com - Company Aggregate Debt|Singular Genomics - Company Total Debt|Aggregate Debt Obligations RGLS|SYRS - Company Debts|TBIO (Telesis Bio, Inc) - Company Aggregate Debt|TCON (TRACON Pharmaceuticals) - Company Total Debt|UBX - Company Total Debt Obligations